X Bioscience Public Company Limited

SET:XBIO-R Stock Report

Market Cap: ฿851.5m

X Bioscience Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Amnart Lertpresertwong

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureless than a year
Board average tenureless than a year

Recent management updates

Recent updates

CEO

Amnart Lertpresertwong (53 yo)

no data
Tenure

Mr. Amnart Lertpresertwong is Director of X Bioscience Public Company Limited from December 22, 2025 and served as its Chief Operating Officer of Construction Division since February 24, 2026 until August...

Leadership Team

NamePositionTenureCompensationOwnership
Amnart Lertpresertwong
CEO & Directorno datano datano data
Ramjai Sriprommin
CFO & Company Secretaryless than a yearno datano data
Michael Fernandez
Director of Investmentsno datano datano data
Pongsak Nawalak
Director of Technologyno datano datano data
Nitchanun Yammeesri
Company Secretaryless than a yearno datano data
0.2yrs
Average Tenure
49yo
Average Age

Experienced Management: XBIO-R's management team is not considered experienced ( 0.2 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Amnart Lertpresertwong
CEO & Directorless than a yearno datano data
Saowanee Khaoubol
Vice Chairman4.6yrsno datano data
Phurit Wongkham
Directorless than a yearno datano data
Sarayut Rueangsuwan
Independent Director1.3yrs฿100.00kno data
Supoj Pannoi
Independent Chairmanless than a yearno datano data
Thansuda Rungruang
Directorless than a yearno datano data
Poramin Nillaphan
Independent Directorless than a yearno datano data
Radchada Lurang
Independent Directorless than a yearno datano data
0.6yrs
Average Tenure
44yo
Average Age

Experienced Board: XBIO-R's board of directors are not considered experienced ( 0.6 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/19 11:14
End of Day Share Price 2026/08/19 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

X Bioscience Public Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.